According to an article on CNN.com, Geron’s CEO, Dr. Tom Okarma, confirmed timelines for Geron to initiate human clinical trials with their embryonic stem (ES) cell-based treatment for spinal co… more →
The Regeneration Stationjrowley wrote 1 year ago: According to an article on CNN.com, Geron’s CEO, Dr. Tom Okarma, confirmed timelines for Geron … more →
jrowley wrote 1 year ago: Geron yesterday announced the issuance of US patent #7,326,572, helping to extend their patent prote … more →
jrowley wrote 1 year ago: The FDA has scheduled an April 10, 2008 meeting to “discuss scientific considerations for safe … more →
jrowley wrote 2 years ago: An interesting study was published this week in the Journal of Neuroimmunology spurring a press rele … more →